Clinical Laserthermia Systems AB (publ) (CLS-B.ST)

SEK 3.84

(-2.04%)

Market Cap (In SEK)

53.48 Million

Revenue (In SEK)

8.27 Million

Net Income (In SEK)

-79.79 Million

Avg. Volume

56 Thousand

Currency
SEK
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
3.6-37.6
PE
-
EPS
-
Beta Value
0.211
ISIN
SE0002756130
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. Dan Johansson Mogren
Employee Count
-
Website
https://www.clinicallaser.se
Ipo Date
2009-04-16
Details
Clinical Laserthermia Systems AB (publ) develops treatment tools for diseased tissue under the TRANBERG brand in Sweden. The company offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. It also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers provides multiple options to control treatment. In addition, the company offers various gauge laser applicators, as well as provides temperature and treatment monitoring devices. Clinical Laserthermia Systems AB (publ) was incorporated in 2006 and is headquartered in Lund, Sweden.